about
Complicated infective endocarditis necessitating ICU admission: clinical course and prognosisThe Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate ImmunityPeptide Bbeta(15-42) preserves endothelial barrier function in shock.The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia.CD14 is a coreceptor of Toll-like receptors 7 and 9.A reversible gene trap collection empowers haploid genetics in human cells.Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection.Imprinted expression in cystic embryoid bodies shows an embryonic and not an extra-embryonic patternDNA Repair Cofactors ATMIN and NBS1 Are Required to Suppress T Cell Activation.Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes.From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection.Diabetes and infection: is there a link?--A mini-review.Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer.Accumulating evidence for a role of oxidized phospholipids in infectious diseases.Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment.Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo.Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia.PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo.Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood.Tyrosine kinase 2 controls IL-1ß production at the translational level.Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice.Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor.Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice.Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole.Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis.Erratum: Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways.The protein tyrosine kinase Tec regulates a CD44highCD62L- Th17 subset.
P50
Q24791037-432ACCA5-18C8-4F8D-BC18-911763CE81A3Q28115270-FB8332AB-567B-4CB6-A84F-98F892C9774DQ33436206-D8FEE481-682C-4EF2-911D-BF3AEF94EDD4Q33748966-06876C6F-FB62-4AA7-B5EB-166B8171931AQ34340654-0111C2B2-E248-4836-BA92-C9844F7A743EQ34380363-66813FAB-C184-41AC-8EBF-1F4422000EE9Q34427919-30398590-B794-4D01-9912-F578BEAAEED5Q35060864-44C7A880-61E8-4539-B432-8E30476D898DQ35614628-A5F6EA50-52D5-4642-AE2E-B47B6C007132Q36257283-4110BC71-1847-4144-873D-54D18899E430Q36406996-BF2AF04E-22B8-4FF7-82FC-E0F7CD5BC2DAQ36966966-2E3591CC-1E38-4BE8-A03C-29D7C450A4E1Q37052936-21A9ED5E-8BBF-48EA-B79F-7D6112E59EDCQ37300237-5DEAB69A-4233-4593-97D2-64571EE582C3Q38062723-D9465260-5718-4667-8BF3-B53DA41542C1Q38080047-AA00598E-5B61-4508-8912-51E626762E90Q38269716-8F455691-DDA3-4481-991F-ACE5D850987BQ38304270-E5B658D2-899F-4EFA-8A35-F3F807178155Q38947692-2A9B5265-F1F4-4F4E-A514-4B939EBBFE8EQ39096019-871D4738-F021-4F55-BD89-4F7933722BC1Q39141521-DF8F270F-6E76-4722-8461-0479E8A98012Q39141528-BBE51108-A981-4251-911B-E2DF601F6D6FQ39156671-F45542D8-7297-470F-AC7E-4E33C3D26663Q39259618-4531CA0F-C7B8-4B1A-AF03-F80A84F060F4Q39617084-2737C106-9E90-4167-BF3F-28D01E55603CQ39666887-FECC633A-0221-4EA3-B604-34846C122D18Q39666893-6906FFDB-DE85-41D9-ADB4-279161B3099CQ39677050-698EB18B-1C06-43EE-A626-A24CE7821F73Q39699991-D94749A6-39D7-4C90-A5D3-201F70CB5891Q40010157-1D9F232A-FB7D-4077-B907-5EBB12C8DE3DQ40403995-CD562AEB-2FCC-4BF7-AF1E-D89D27B3263BQ40404007-957DBFF9-3009-4AB2-8B4B-0A7E4492DD8CQ40469729-4E4FC404-B72F-4758-8852-D39E9C334CCDQ40474101-C631D3EA-00AC-4A24-962C-6D655AC8C7D7Q40617052-52DCBDA4-7629-4631-859F-72331047DF22Q40631024-5ECB54BA-03C2-4056-95F6-77C6CB792A97Q40760672-44CFD88B-313B-4D25-A2CC-7C2098581212Q41616021-3F8889E8-A949-44C5-BEBC-8E01F51707ADQ42774051-73134FE9-E6A0-49EE-B00F-0E295F112590Q42876500-A9EA51FA-D1F0-404C-83F6-0E5FAA85717E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sylvia Knapp
@ast
Sylvia Knapp
@en
Sylvia Knapp
@es
Sylvia Knapp
@nl
Sylvia Knapp
@sl
type
label
Sylvia Knapp
@ast
Sylvia Knapp
@en
Sylvia Knapp
@es
Sylvia Knapp
@nl
Sylvia Knapp
@sl
prefLabel
Sylvia Knapp
@ast
Sylvia Knapp
@en
Sylvia Knapp
@es
Sylvia Knapp
@nl
Sylvia Knapp
@sl
P106
P21
P31
P496
0000-0001-9016-5244